Skip to content

enGene Therapeutics Inc.

ENGN · XNAS

CIK 1980845fmd_11GYM23DKG83G0CN0EB7B5NRKZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Nov 01, 2021 to Jul 31, 2026, 16 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading